Decoding Non-Neuronal Mechanisms and Therapeutic Targets in Huntington's Disease Through Integrative Transcriptomics...

Area of Science:

• Computational biology
• Genetics
• Neuroscience

Background:

• Huntington's disease (HD) is an inherited neurodegenerative disorder caused by expanded CAG repeats in the huntingtin gene.
• Current therapeutic targets for HD are limited, hindering effective treatment development.

Purpose of the Study:

• To identify novel therapeutic targets for Huntington's disease using an integrated computational approach.
• To advance understanding of HD pathophysiology by exploring non-neuronal mechanisms.

Main Methods:

• Applied machine learning (ML) and transcriptomic analysis to identify differentially expressed genes (DEGs) in HD patient samples.
• Utilized feature selection techniques (mRMR, RFE) and multiple classifiers for DEG screening.
• Constructed gene regulatory networks (GRNs) and performed literature curation for target validation.

Main Results:

• Identified 138 DEG candidates, highlighting key genes such as TXNIP, TNIP3, HTR1D, ADRB1, and FOXP1.
• Revealed the involvement of non-neuronal mechanisms including endothelial dysfunction, metabolic imbalance, and impaired phagocytosis in HD.
• Advanced knowledge of HD therapeutic targets, molecular pathways, and gene interactions.

Conclusions:

• The study successfully identified promising novel drug targets for Huntington's disease.
• The findings suggest potential new therapeutic implications for HD treatment.
• The integrated computational strategy provides a broader perspective on HD pathophysiology beyond classical neuronal processes.